Targeting the Body’s Own Misfolded Enzyme
Chaperone Molecule Development offers a unique therapeutic approach that is only applicable to certain individuals. This strategy involves small, orally available molecules—known as pharmacologic chaperones—that enter the body’s cells and bind to the patient's existing, but misfolded, alpha-galactosidase A enzyme. This binding...
English 
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt